Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption
- 1 October 2010
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 296 (1) , 106-112
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- In vitro targeted photodynamic therapy with a pyropheophorbide‐a conjugated inhibitor of prostate‐specific membrane antigenThe Prostate, 2009
- Photodynamic therapy for prostate cancer—a review of current status and future promiseNature Reviews Endocrinology, 2009
- Switch in Fas-activated death signaling pathway as result of keratin 8/18-intermediate filament lossApoptosis, 2008
- Motexafin Lutetium-Photodynamic Therapy of Prostate Cancer: Short- and Long-Term Effects on Prostate-Specific AntigenClinical Cancer Research, 2008
- Targets of Caspase-6 Activity in Human Neurons and Alzheimer DiseaseMolecular & Cellular Proteomics, 2008
- Optimization of light source parameters in the photodynamic therapy of heterogeneous prostatePhysics in Medicine & Biology, 2008
- The human keratins: biology and pathologyHistochemistry and Cell Biology, 2008
- Dual roles of intermediate filaments in apoptosisExperimental Cell Research, 2007
- Photodynamic Therapy with Pyropheophorbide-a Methyl Ester in Human Lung Carcinoma Cancer Cell: Efficacy, Localization and Apoptosis¶Photochemistry and Photobiology, 2002
- Actin cleavage by CPP-32/apopain during the development of apoptosisOncogene, 1997